tickrz reports
Mallinckrodt Plc (MNK)
Healthcare | Drugs
22.27  -0.13%
MNK vs DRUGS SECTOR & S&P 500
VALUATION
MNKSECTORS&P 500
P/E RATIO3.383820.18
EV/EBITDA RATIO6.28121.612.15
P/S RATIO0.726.22.14
P/B RATIO0.427.33.29
QUALITY
RETURN ON EQUITY12.41%15.79%13.65%
RETURN ON CAPITAL27.18%19.38%10.09%
NET MARGIN14.46%14.46%9.76%
DIVIDEND ANALYSIS
DIVIDEND YIELD
0%
PAYOUT RATION/A
3 YR DIVIDEND GROWTHN/A
FINANCIAL STRENGTH
PIOTROSKI F SCORE
6 OUT OF 9
DEBT-TO-EQUITY114%
INTEREST COVERAGE1.4x
CURRENT RATIO1.38
GROWTH
5 YR EPS GROWTH13.48%
5 YR SPS GROWTH10.83%
5 YR BPS GROWTH9.67%
Mallinckrodt Plc Filings

Annual & Quarterly Reports

Events or Changes Between Quarters (8-K)


Changes in Ownership